IRWD · Ironwood Pharmaceuticals Inc
United States · RS rating 40 · As of 2026-11-03
| Price | 3.50 USD |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 40 / 46 / 37 / 92 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 30 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -104.3% |
| Sales growth Q/Q | -60.9% |
| Distance from 52-week high | +35.1% |
| Market cap (USD) | $618.0M |